2022 Biosimilar Awareness Week: 30 May – 3 June

30 May 2022 - Marking a new dawn in medicine choice and affordability. ...

Read more →

Remake of National Health (Supply of Pharmaceutical Benefits – Under Co-payment Data and Claims for Payment) Rules 2022

25 May 2022 - The Department has recently remade the National Health (Claims and under co-payment data) Rules 2012, now ...

Read more →

Review of discount rate in the PBAC Guidelines

25 May 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...

Read more →

Medicines Australia ready to work with new Government on medicines reform and life sciences

23 May 2022 - Medicines Australia congratulates Anthony Albanese and the Labor Party on their election win and forming Government. ...

Read more →

‘It’s scary, the thought of not having access’: new anti-depressant considered for PBS

22 May 2022 - A drug described as a last option for people with treatment-resistant depression, which psychiatrists say is ...

Read more →

People dying of COVID while life-saving drugs go unused, doctors say

21 May 2022 - Top doctors have warned that vulnerable patients who test positive to COVID-19 are missing out on ...

Read more →

Medicines Australia puts spotlight on reform priority for the next Government

20 May 2022 - Medicines Australia has set the scene for major health reform by the next Government by alerting ...

Read more →

Plea to make new depression 'spray' affordable

19 May 2022 - Mental health experts say a nasal spray to help relieve depression should be subsidised to make ...

Read more →

Major parties committed to major medicines policy reform and reviews – whoever wins on Saturday

19 May 2022 - Medicines Australia has been assured in official communications from the respective Campaign Headquarters that both the ...

Read more →

Discount rate adjustment for the health of future generations

17 May 2022 - Medicines Australia has released a video detailing the need for Australia to adjust its discount rate ...

Read more →

Remake of the National Health (Pharmaceuticals and Vaccines – Cost Recovery) Regulations 2009

11 May 2022 - The Department has recently remade the National Health (Pharmaceutical and Vaccines—Cost Recovery) Regulations 2009 (2009 Regulations), ...

Read more →

High-risk COVID-19 patients can now get two antiviral prescription drugs — but some are still missing out

10 May 2022 - For Australians at high risk of developing severe COVID-19, getting access to potentially lifesaving treatment recently ...

Read more →

Next Health Minister must restart the National Medicines Policy Review

10 May 2022 - Medicines Australia has released a video outlining the importance of restarting the National Medicines Policy Review ...

Read more →

Updated agenda for the July 2022 PBAC meeting

6 May 2022 - The agenda for the July 2022 PBAC meeting has been updated.  ...

Read more →

Insights from the March 2022 PBAC meeting (part 4)

5 May 2022 - The apparent high recommendation rate for the March 2022 meeting does have some downsides. ...

Read more →